Clinical application of a functional 3D ex vivo test to predict therapeutic response in patients with HGG: A progression-free survival analysis.

Authors

null

Lindsay J Lipinski

Roswell Park Comprehensive Cancer Center, Buffalo, NY

Lindsay J Lipinski , Ajay Prakash Abad , Robert Alan Fenstermaker , Andrew J. Fabiano , William Jeffery Edenfield , Charles Kanos , Navid Redjal , Analiz Rodriguez , Alireza Mansouri , Brad Zacharia , Nicholas A. Butowski , Jesse Jia-Xin Liu , Seunggu Jude Han , Mateo Ziu , Adam Louis Cohen , Ashley M. Smith , Tessa DesRochers , Cecile Rose T. Vibat

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Central Nervous System Tumors

Track

Central Nervous System Tumors

Sub Track

Primary CNS Tumors–Glioma

Clinical Trial Registration Number

NCT03561207

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 2031)

DOI

10.1200/JCO.2022.40.16_suppl.2031

Abstract #

2031

Poster Bd #

369

Abstract Disclosures

Similar Posters

First Author: Howard Colman

First Author: Dorota Goplen

First Author: Kerrie Leanne McDonald

First Author: Alba Ariela Brandes